Epidemiological Interactions between Urogenital and Intestinal Human Schistosomiasis in the Context of Praziquantel Treatment across Three West African Countries

PLoS Negl Trop Dis. 2015 Oct 15;9(10):e0004019. doi: 10.1371/journal.pntd.0004019. eCollection 2015.

Abstract

Background: In many parts of sub-Saharan Africa, urogenital and intestinal schistosomiasis co-occur, and mixed species infections containing both Schistosoma haematobium and S. mansoni can be common. During co-infection, interactions between these two species are possible, yet the extent to which such interactions influence disease dynamics or the outcome of control efforts remains poorly understood.

Methodology/principal findings: Here we analyse epidemiological data from three West African countries co-endemic for urogenital and intestinal schistosomiasis (Senegal, Niger and Mali) to test whether the impact of praziquantel (PZQ) treatment, subsequent levels of re-infection or long-term infection dynamics are altered by co-infection. In all countries, positive associations between the two species prevailed at baseline: infection by one species tended to predict infection intensity for the other, with the strength of association varying across sites. Encouragingly, we found little evidence that co-infection influenced PZQ efficacy: species-specific egg reduction rates (ERR) and cure rates (CR) did not differ significantly with co-infection, and variation in treatment success was largely geographical. In Senegal, despite positive associations at baseline, children with S. mansoni co-infection at the time of treatment were less intensely re-infected by S. haematobium than those with single infections, suggesting competition between the species may occur post-treatment. Furthermore, the proportion of schistosome infections attributable to S. mansoni increased over time in all three countries examined.

Conclusions/significance: These findings suggest that while co-infection between urinary and intestinal schistosomes may not directly affect PZQ treatment efficacy, competitive interspecific interactions may influence epidemiological patterns of re-infection post-treatment. While re-infection patterns differed most strongly according to geographic location, interspecific interactions also seem to play a role, and could cause the community composition in mixed species settings to shift as disease control efforts intensify, a situation with implications for future disease management in this multi-species system.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anthelmintics / therapeutic use*
  • Coinfection / drug therapy*
  • Coinfection / parasitology
  • Female
  • Humans
  • Male
  • Praziquantel / therapeutic use*
  • Schistosomiasis haematobia / drug therapy*
  • Schistosomiasis haematobia / parasitology
  • Schistosomiasis mansoni / drug therapy*
  • Schistosomiasis mansoni / parasitology

Substances

  • Anthelmintics
  • Praziquantel

Grants and funding

The Senegal and Niger studies were funded by the EU grant CONTRAST (FP6 STREP contract no: 032203, http://www.eu-contrast.eu, and Mali data collection was funded by a Bill and Melinda Gates Foundation Grant to the Schistosomiasis Control Initiative (SCI). SCLK was funded by ICOSA funding from the Department for International Development (UK) to to SCI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.